The UNMC College of Medicine received grant and funding awards representing nearly $3.5 million in new funding in November.
Stacey Gilk, PhD, pathology/microbiology, received a grant of $230,250 from DHHS/NIH/NIAD for a study of coxiella secreted proteins mediating inter-organelle membrane contact sites.
Olga Taraschenko, MD, PhD, neurological sciences, received a grant of $109,890 from Nebraska DHHS for in vivo monitoring of neurogenesis in encephalitis.
Bin Duan, PhD, internal medicine-cardiovascular, received a grant of $81,652 from Nebraska DHHS for a study of targeted MSC exosomes for neuropathic pain relief.
Aviva Abosch, MD, PhD, neurosurgery, received a grant of $50,031 from the University of Colorado-Anschutz Medical Campus for a study of deep brain stimulation (DBS) for severe treatment refractory methamphetamine use disorder.
Anna Dunaevsky, PhD, neurological sciences, received a grant of $50,000 from the FRAXA Research Foundation for a study on astrocyte contribution to sensory hypersensitivity in FXS.
Vivek Dutt, MBBS, orthopedic surgery, received a grant of $12,308 from the University of Nebraska at Omaha for a study on the mechanics of overground, dry and aquatic treadmill walking in children and adolescents with cerebral palsy.
Sidharth Mahapatra, MD, PhD, pediatrics-critical care, received a grant of $9,999 from the University of Pennsylvania for PROSpect — The Prone and Oscillation Pediatric Clinical Trial.
Cyrus Desouza, MBBS, internal medicine-DEM, received a grant of $6,000 from the Nebraska Educational Biomedical Research Association as an ICA for Payton Hurlburt.
Industry-sponsored grants and contracts:
The following industry-sponsored grants and contracts were received.
David F. Mercer, MD, PhD, surgery-transplant, received funding for a trial to evaluate the long-term safety of apraglutide in short bowel syndrome.
Prasanth Ravipati, MD, internal medicine-nephrology, received funding for a trial to evaluate the efficacy and safety of sibeprenlimab administered subcutaneously in subjects with immunoglobulin A nephropathy.
Sarah Holstein, MD, PhD, internal medicine-oncology/hematology, received funding for a study of elranatamab, a B-cell maturation antigen CD3 bispecific antibody, in combination with other anti-cancer treatments in participants with relapsed/refractory multiple myeloma.
Christopher D’Angelo, MD, internal medicine-oncology/hematology, received funding for a study of FT819 in subjects with B-cell malignancies.
Andrew Goldsweig, MD, internal medicine-cardiovascular, received funding for a multi-center controlled clinical investigation comparing PFO outcomes of the Occlutech Flex II PFO occluder to standard of care PFO occlusion.
Matthew Lunning, DO, internal medicine-oncology/hematology, received funding for a multicenter study of MT-101 in subjects with CD5+ relapsed/refractory peripheral T cell lymphoma.
William Rizzo, MD, pediatrics-pediatrics metabolism, received funding for a study of the safety, biochemical efficacy and exploratory clinical effects of Oral ADX-629 in subjects with Sjogren-Larsson Syndrome.
Andrew Rorie, MD, internal medicine-allergy/immunology, received funding for registry agreement: Assessing long-term outcomes of DUPIXENT treatment in patients with chronic rhinosinusitis with nasal polyposis.